Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 15 | $6,456,499 |
Sells | 2 | $279,296 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Mar 2025 16:05 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 25 Mar 2025 | Purchase | 7,800 | 7.78 | 60,684 | D |
26 Mar 2025 16:03 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 26 Mar 2025 | Purchase | 137,100 | 7.29 | 999,459 | D |
25 Mar 2025 17:18 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 24 Mar 2025 | Purchase | 7,000 | 8.21 | 57,470 | D |
25 Mar 2025 17:15 | IMNM | Immunome Inc | TSAI PHILIP | Chief Technology Officer | 24 Mar 2025 | Purchase | 12,300 | 8.42 | 103,566 | D |
03 Feb 2025 21:01 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 31 Jan 2025 | Purchase | 150,000 | 7.75 | 1,162,500 | D |
25 Nov 2024 08:41 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 21 Nov 2024 | Purchase | 66,057 | 9.5412 | 630,263 | D |
25 Nov 2024 08:41 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 22 Nov 2024 | Purchase | 33,943 | 9.7787 | 331,918 | D |
25 Nov 2024 08:35 | IMNM | Immunome Inc | LECHLEIDER ROBERT | Chief Medical Officer | 21 Nov 2024 | Purchase | 15,805 | 9.478 | 149,800 | D |
25 Nov 2024 08:33 | IMNM | Immunome Inc | TSAI PHILIP | Chief Technology Officer | 21 Nov 2024 | Purchase | 21,000 | 9.43 | 198,030 | D |
20 Sep 2024 19:26 | IMNM | Immunome Inc | ROSETT MAX | Chief Financial Officer | 19 Sep 2024 | Sale | 14,380 | 16.01 | 230,224 | D |
19 Aug 2024 21:07 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 16 Aug 2024 | Purchase | 7,000 | 13.944 | 97,608 | D |
19 Aug 2024 21:05 | IMNM | Immunome Inc | HIGGINS JACK | Chief Scientific Officer | 15 Aug 2024 | Sale | 3,524 | 13.925 | 49,072 | D |
22 May 2024 16:49 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 21 May 2024 | Purchase | 2,000 | 13.5699 | 27,140 | D |
21 May 2024 16:13 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 21 May 2024 | Purchase | 20,434 | 13.7784 | 281,548 | D |
21 May 2024 16:13 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 20 May 2024 | Purchase | 79,566 | 13.907 | 1,106,524 | D |
04 Oct 2023 17:35 | IMNM | Immunome Inc | SIEGALL CLAY B | President and CEO | 02 Oct 2023 | Purchase | 169,204 | 5.91 | 999,996 | D |
04 Oct 2023 17:32 | IMNM | Immunome Inc | TURNER BRUCE | Chief Strategy Officer | 02 Oct 2023 | Purchase | 42,300 | 5.91 | 249,993 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)